Clinical Trial: Heparin-induced Thrombocytopenia (HIT II) in Liver Transplant Recipients

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: Heparin-induced Thrombocytopenia (HIT II) in Liver Transplant Recipients: a Prospective Multivariate Analysis of Prognostic Factors and Haemostaseological Findings

Brief Summary: In a prospective observational study the incidence of Heparin-induced Thrombocytopenia (HIT) Type 2 after orthotopic liver transplantation, associated factors, and hemostaseological findings in thrombocytes and anti-body patterns is going to be investigated.

Detailed Summary: The investigators examined the frequency of anti-PF4/heparin antibodies (IgG/M/A; EIA) and their functional activity (HIPA) in 38 whole organ deceased donor liver transplant recipients. Additionally, demographic, clinical, donor- and recipient-specific parameters and laboratory findings (ALAT, ASAT, cholinesterase) were investigated.
Sponsor: CHIR-Net

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: CHIR-Net

Dates:
Date Received: March 30, 2012
Date Started: January 2010
Date Completion:
Last Updated: July 31, 2012
Last Verified: July 2012